Pergolide is a dopamine agonist drug used to treat Parkinson's disease. It works by increasing the amount of dopamine available in the brain, which helps to improve muscle stiffness, tremors, and other symptoms of Parkinson's disease. Pergolide is usually taken orally once a day, but dosage and frequency may vary depending on the patient and their individual needs. Side effects may include nausea, dizziness, drowsiness, and dry mouth. People with certain medical conditions should not take pergolide, and it should be used with caution in those taking other medications, as interactions may occur.
Pergolide is a medication that was previously used to treat Parkinson's disease, but it's important to understand its current status:
Historical Use:
- Approved in 1982 for Parkinson's disease.
- Acted by mimicking dopamine, a brain chemical involved in movement control.
Current Use:
- Withdrawn in the US (2007): Due to increased risk of heart valve problems.
- Limited availability elsewhere: In some countries, it may still be used for Parkinson's disease or other conditions, but with careful monitoring due to the safety concerns.
- Veterinary medicine: Pergolide (under the brand name Prascend) is used for a specific condition in horses (Equine Cushing's Syndrome).